Analysts Set Trupanion, Inc. (NASDAQ:TRUP) PT at $41.60

Shares of Trupanion, Inc. (NASDAQ:TRUP) have been assigned a consensus rating of “Moderate Buy” from the six analysts that are currently covering the stock, MarketBeat reports. Three investment analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $41.60.

Several equities research analysts recently weighed in on TRUP shares. Atlantic Securities set a $42.00 price target on Trupanion in a research report on Wednesday, July 15th. Zacks Research raised Trupanion from a “hold” rating to a “strong-buy” rating in a research report on Friday, July 24th. Stifel Nicolaus set a $28.00 target price on shares of Trupanion in a report on Friday, June 26th. Finally, Weiss Ratings raised shares of Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday.

Trupanion Price Performance

TRUP stock opened at $30.60 on Monday. Trupanion has a 1 year low of $21.16 and a 1 year high of $49.90. The company has a market cap of $1.34 billion, a P/E ratio of 57.74, a PEG ratio of 2.23 and a beta of 1.39. The firm has a 50-day moving average of $25.56 and a 200 day moving average of $26.11. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The business had revenue of $392.93 million for the quarter, compared to analysts’ expectations of $389.72 million. During the same period in the previous year, the firm posted $0.22 EPS. The business’s revenue was up 11.1% on a year-over-year basis. On average, sell-side analysts forecast that Trupanion will post 0.59 EPS for the current year.

Insider Buying and Selling at Trupanion

In related news, COO John R. Gallagher sold 3,603 shares of the company’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $21.69, for a total value of $78,149.07. Following the sale, the chief operating officer owned 33,065 shares in the company, valued at $717,179.85. This represents a 9.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Steve Weinrauch sold 6,674 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $22.00, for a total value of $146,828.00. Following the transaction, the executive vice president directly owned 78,062 shares of the company’s stock, valued at approximately $1,717,364. This trade represents a 7.88% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 18,785 shares of company stock worth $422,862 over the last three months. Company insiders own 5.58% of the company’s stock.

Institutional Investors Weigh In On Trupanion

Institutional investors have recently modified their holdings of the stock. Kelleher Financial Advisors purchased a new stake in Trupanion during the 2nd quarter valued at about $42,000. Kemnay Advisory Services Inc. purchased a new position in Trupanion in the fourth quarter worth about $64,000. Parallel Advisors LLC raised its holdings in Trupanion by 1,831.9% in the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider’s stock worth $47,000 after buying an additional 1,722 shares during the last quarter. Quantbot Technologies LP bought a new position in shares of Trupanion in the second quarter worth approximately $89,000. Finally, Advisory Services Network LLC purchased a new stake in shares of Trupanion during the third quarter valued at approximately $160,000.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.